Dear Customer,
Genomica is pleased to present PRENATALAUTISM, an advanced non-invasive prenatal screening test that analyzes trophoblastic-derived circulating cell-free fetal DNA (cfDNA) from a maternal blood sample to identify fetal mutations responsible for severe genetic diseases associated with Autism Spectrum Disorders.

PRENATALAUTISM represents a significant technological advancement compared to conventional NIPTs, which, due to their low resolution, are limited to identifying fetal chromosomal aneuploidies and structural chromosomal abnormalities.

Thanks to its advanced technology, PRENATALAUTISM can detect:

• Genetic diseases associated with Autism Spectrum Disorders
• Severe, clinically recognized, genetic disorders with de novo onset
• Severe, clinically recognized, inherited genetic diseases
• Common fetal aneuploidies (e.g., Trisomy 21, Trisomy 18, Trisomy 13, Monosomy X, Trisomy X, XXY, XYY)
• Rare fetal aneuploidies (e.g., Trisomy 9, Trisomy 16, Trisomy 22, among the most frequent rare aneuploidies)
• Structural chromosomal abnormalities (segmental deletions and duplications >7 Mb) across all chromosomes in the fetal karyotype
• Microdeletion / microduplication syndromes (with a resolution down to 1 Mb in size)
• Microdeletions / microduplications associated with Autism Spectrum Disorders

All this is provided in a single test.

3 SCREENING OPTIONS DESIGNED TO MEET THE NEEDS OF EVERY PREGNANCY






Download the PRENATALAUTISM Brochure
by clicking on the image above

The expected turnaround time is the following:
📍3 working days for fetal chromosomal analysis (rapid reporting service)
📍~15 working days for the analysis of genetic diseases (associated with Autism Spectrum Disorders, inherited conditions, and de novo onset disorders)

Further information is available on the dedicated website www.prenatalautism.it or by contacting our team of geneticists.

Our Sales Department is available to provide further details on the test’s operational procedures and to explore collaboration opportunities with Genomica to integrate the test into clinical practice.

If you are interested in receiving more information on PRENATALAUTISM, we kindly invite you to write to us:

Contact Genomica

We look forward to sharing the most advanced and innovative diagnostic solutions in the field of genetics.

GENOMICA srl
Marketing and Communication Department